| Name | Title | Contact Details |
|---|
Digital Benefit Advisors - Southern California is part of the nation’s largest independent employee benefits-only agency for mid-market employers. Our firm delivers holistic employee benefits solutions that focus on enhancing an organization’s return on investment via innovative plan designs, progressive negotiation strategies, risk management solutions, and human resources and benefits technology options. Our national footprint enables us to offer unique services and highly competitive rates for our clients, including access to our Private Exchange known as our Benefits Marketplace.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
United States Renal Data System is a Minneapolis, MN-based company in the Business Services sector.
Penn Virginia Resource Partners, L.P. is a Wayne, PA-based company in the Business Services sector.